Parallel Advisors’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.02K Buy
178
+29
+19% +$644 ﹤0.01% 3118
2025
Q4
$3.86K Hold
149
﹤0.01% 2932
2025
Q3
$3.84K Hold
149
﹤0.01% 2880
2025
Q2
$3.56K Hold
149
﹤0.01% 2861
2025
Q1
$3.7K Hold
149
﹤0.01% 2784
2024
Q4
$2.81K Buy
149
+122
+452% +$2.14K ﹤0.01% 2848
2024
Q3
$406 Buy
+27
New +$462 ﹤0.01% 3213
2024
Q2
Sell
-223
Closed -$6.52K 3402
2024
Q1
$6.52K Sell
223
-57
-20% -$1.75K ﹤0.01% 2448
2023
Q4
$9.45K Buy
280
+220
+367% +$6.44K ﹤0.01% 2315
2023
Q3
$1.84K Buy
60
+58
+2,900% +$2.09K ﹤0.01% 2850
2023
Q2
$80 Sell
2
-31
-94% -$1.28K ﹤0.01% 3299
2023
Q1
$1.35K Buy
+33
New +$1.31K ﹤0.01% 2887
2022
Q4
Sell
-2
Closed 3498
2022
Q3
$0 Sell
2
-1
-33% -$56 ﹤0.01% 3422
2022
Q2
$0 Buy
+3
New +$197 ﹤0.01% 3280

Other funds holding PCRX